CORR Insights®: Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?
作者信息
Tang Xiaodong
机构信息
Musculoskeletal Tumor Center, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.
出版信息
Clin Orthop Relat Res. 2020 Mar;478(3):560-562. doi: 10.1097/CORR.0000000000001011.
Abstract
摘要
相似文献
1
CORR Insights®: Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?CORR见解®：列线图能否预测肢体局限性软组织肉瘤的术后伤口并发症？
Clin Orthop Relat Res. 2020 Mar;478(3):560-562. doi: 10.1097/CORR.0000000000001011.
2
Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?是否可以使用诺莫图预测肢体局限性软组织肉瘤的术后伤口并发症？
Clin Orthop Relat Res. 2020 Mar;478(3):550-559. doi: 10.1097/CORR.0000000000000959.
3
Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.日本骨与软组织肿瘤登记处报告：预测躯干和四肢原发性软组织肉瘤患者预后的列线图的建立。
BMC Cancer. 2019 Jul 4;19(1):657. doi: 10.1186/s12885-019-5875-y.
4
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.针对腹膜后、四肢或躯干原发性脂肪肉瘤患者的亚型特异性预后列线图。
Ann Surg. 2006 Sep;244(3):381-91. doi: 10.1097/01.sla.0000234795.98607.00.
5
CORR Insights®: Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.CORR见解®：保险状况与原发性骨和四肢软组织肉瘤的生存及治疗之间是否存在关联？一项监测、流行病学和最终结果（SEER）数据库研究。
Clin Orthop Relat Res. 2020 Mar;478(3):537-539. doi: 10.1097/CORR.0000000000000932.
6
A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation.保肢手术后不进行辅助放疗的肢体软组织肉瘤局部复发风险的术后列线图。
Ann Surg. 2012 Feb;255(2):343-7. doi: 10.1097/SLA.0b013e3182367aa7.
7
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.发展和外部验证两种列线图，以预测成人肢体局限性软组织肉瘤手术后的总生存和远处转移发生：回顾性分析。
Lancet Oncol. 2016 May;17(5):671-80. doi: 10.1016/S1470-2045(16)00010-3. Epub 2016 Apr 5.
8
CORR Insights®: Does Vacuum-assisted Closure Reduce the Risk of Wound Complications in Patients With Lower Extremity Sarcomas Treated With Preoperative Radiation?CORR见解®：负压封闭引流能否降低术前放疗的下肢肉瘤患者伤口并发症的风险？
Clin Orthop Relat Res. 2019 Apr;477(4):775-776. doi: 10.1097/CORR.0000000000000469.
9
Risk factors for significant wound complications following wide resection of extremity soft tissue sarcomas.肢体软组织肉瘤广泛切除术后发生重大伤口并发症的危险因素。
Clin Orthop Relat Res. 2013 Nov;471(11):3612-7. doi: 10.1007/s11999-013-3130-4. Epub 2013 Jun 28.
10
Effect of negative pressure wound therapy after surgical removal of deep-seated high-malignant soft tissue sarcomas of the extremities and trunk wall-study protocol for a randomized controlled trial.四肢和躯干壁深部高恶性软组织肉瘤切除术后负压伤口治疗的效果-一项随机对照试验的研究方案。
Trials. 2022 Jun 18;23(1):507. doi: 10.1186/s13063-022-06468-6.
本文引用的文献
1
Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?是否可以使用诺莫图预测肢体局限性软组织肉瘤的术后伤口并发症？
Clin Orthop Relat Res. 2020 Mar;478(3):550-559. doi: 10.1097/CORR.0000000000000959.
2
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses.帕唑帕尼治疗晚期软组织肉瘤的安全性和疗效：PALETTE（EORTC 62072）亚组分析。
BMC Cancer. 2019 Aug 13;19(1):794. doi: 10.1186/s12885-019-5988-3.
3
Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: A systematic review and meta-analyses.四肢软组织肉瘤切除术后伤口并发症的风险因素：系统评价和荟萃分析。
J Plast Reconstr Aesthet Surg. 2019 Sep;72(9):1449-1464. doi: 10.1016/j.bjps.2019.05.041. Epub 2019 May 23.
4
Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group.新辅助帕唑帕尼治疗高危软组织肉瘤：德国跨学科肉瘤研究组的定量动态F-FDG PET/CT研究
Cancers (Basel). 2019 Jun 8;11(6):790. doi: 10.3390/cancers11060790.
5
Soft tissue sarcoma of the hand: Is unplanned excision a problem?手部软组织肉瘤：未计划切除是个问题吗？
Eur J Surg Oncol. 2019 Jul;45(7):1281-1287. doi: 10.1016/j.ejso.2019.03.024. Epub 2019 Mar 21.
6
Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes.意大利软组织肉瘤：从流行病学数据到临床网络，以改善患者的护理和结局。
Cancer Epidemiol. 2019 Apr;59:258-264. doi: 10.1016/j.canep.2019.02.012. Epub 2019 Mar 11.
7
Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue Sarcomas.术前放疗后四肢软组织肉瘤伤口并发症的时间依赖性动态
Eur J Surg Oncol. 2019 Apr;45(4):684-690. doi: 10.1016/j.ejso.2018.09.001. Epub 2018 Oct 6.
8
Identification of predictors for wound complications following preoperative or postoperative radiotherapy in extremity soft tissue sarcoma.识别肢体软组织肉瘤术前或术后放疗后伤口并发症的预测因素。
Eur J Surg Oncol. 2018 Jun;44(6):816-822. doi: 10.1016/j.ejso.2018.02.002. Epub 2018 Feb 9.
9
The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.根治性切除术后躯干和肢体软组织肉瘤的术后并发症的肿瘤学影响。
Ann Surg Oncol. 2017 Nov;24(12):3574-3586. doi: 10.1245/s10434-017-6034-9. Epub 2017 Sep 11.
10
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.瑞戈非尼治疗晚期软组织肉瘤的安全性和有效性（REGOSARC）：一项随机、双盲、安慰剂对照、2 期临床试验。
Lancet Oncol. 2016 Dec;17(12):1732-1742. doi: 10.1016/S1470-2045(16)30507-1. Epub 2016 Oct 14.
Zotero 插件